Global PET Radiopharmaceuticals Market Insights, Forecast to 2025

2018-12-07 / 3900.00 / Pharma & Healthcare / 118 Pages

Description

In 2017, the global PET Radiopharmaceuticals market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the PET Radiopharmaceuticals market based on company, product type, application and key regions.

This report studies the global market size of PET Radiopharmaceuticals in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of PET Radiopharmaceuticals in these regions.
This research report categorizes the global PET Radiopharmaceuticals market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

The various contributors involved in the value chain of PET Radiopharmaceuticals include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the PET Radiopharmaceuticals include
Cardinal Health Inc. (U.S.)
Mallinckrodt plc (Ireland)
GE Healthcare (U.K.)
Lantheus Medical Imaging, Inc. (U.S.)
Bayer AG (Germany)
Bracco Imaging S.p.A (Italy)
Eczacibasi-Monrol Nuclear Products (Turkey)
Nordion, Inc. (Canada)
Advanced Accelerator Applications S.A. (France)
IBA Molecular Imaging (Belgium)

Market Size Split by Type
F-18
Ru-82
Others
Market Size Split by Application
Oncology
Cardiology
Neurology
Others

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global PET Radiopharmaceuticals market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of PET Radiopharmaceuticals market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global PET Radiopharmaceuticals manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the PET Radiopharmaceuticals with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of PET Radiopharmaceuticals submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of PET Radiopharmaceuticals are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of PET Radiopharmaceuticals market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Content

Table of Contents

1 Study Coverage
1.1 PET Radiopharmaceuticals Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global PET Radiopharmaceuticals Market Size Growth Rate by Type
1.4.2 F-18
1.4.3 Ru-82
1.4.4 Others
1.5 Market by Application
1.5.1 Global PET Radiopharmaceuticals Market Size Growth Rate by Application
1.5.2 Oncology
1.5.3 Cardiology
1.5.4 Neurology
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global PET Radiopharmaceuticals Market Size
2.1.1 Global PET Radiopharmaceuticals Revenue 2016-2025
2.1.2 Global PET Radiopharmaceuticals Sales 2016-2025
2.2 PET Radiopharmaceuticals Growth Rate by Regions
2.2.1 Global PET Radiopharmaceuticals Sales by Regions
2.2.2 Global PET Radiopharmaceuticals Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 PET Radiopharmaceuticals Sales by Manufacturers
3.1.1 PET Radiopharmaceuticals Sales by Manufacturers
3.1.2 PET Radiopharmaceuticals Sales Market Share by Manufacturers
3.1.3 Global PET Radiopharmaceuticals Market Concentration Ratio (CR5 and HHI)
3.2 PET Radiopharmaceuticals Revenue by Manufacturers
3.2.1 PET Radiopharmaceuticals Revenue by Manufacturers (2016-2018)
3.2.2 PET Radiopharmaceuticals Revenue Share by Manufacturers (2016-2018)
3.3 PET Radiopharmaceuticals Price by Manufacturers
3.4 PET Radiopharmaceuticals Manufacturing Base Distribution, Product Types
3.4.1 PET Radiopharmaceuticals Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers PET Radiopharmaceuticals Product Category
3.4.3 Date of International Manufacturers Enter into PET Radiopharmaceuticals Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global PET Radiopharmaceuticals Sales by Type
4.2 Global PET Radiopharmaceuticals Revenue by Type
4.3 PET Radiopharmaceuticals Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global PET Radiopharmaceuticals Breakdown Data by Application

6 North America
6.1 North America PET Radiopharmaceuticals by Countries
6.1.1 North America PET Radiopharmaceuticals Sales by Countries
6.1.2 North America PET Radiopharmaceuticals Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America PET Radiopharmaceuticals by Type
6.3 North America PET Radiopharmaceuticals by Application
6.4 North America PET Radiopharmaceuticals by Company

7 Europe
7.1 Europe PET Radiopharmaceuticals by Countries
7.1.1 Europe PET Radiopharmaceuticals Sales by Countries
7.1.2 Europe PET Radiopharmaceuticals Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe PET Radiopharmaceuticals by Type
7.3 Europe PET Radiopharmaceuticals by Application
7.4 Europe PET Radiopharmaceuticals by Company

8 Asia Pacific
8.1 Asia Pacific PET Radiopharmaceuticals by Countries
8.1.1 Asia Pacific PET Radiopharmaceuticals Sales by Countries
8.1.2 Asia Pacific PET Radiopharmaceuticals Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific PET Radiopharmaceuticals by Type
8.3 Asia Pacific PET Radiopharmaceuticals by Application
8.4 Asia Pacific PET Radiopharmaceuticals by Company

9 Central & South America
9.1 Central & South America PET Radiopharmaceuticals by Countries
9.1.1 Central & South America PET Radiopharmaceuticals Sales by Countries
9.1.2 Central & South America PET Radiopharmaceuticals Revenue by Countries
9.1.3 Brazil
9.2 Central & South America PET Radiopharmaceuticals by Type
9.3 Central & South America PET Radiopharmaceuticals by Application
9.4 Central & South America PET Radiopharmaceuticals by Company

10 Middle East and Africa
10.1 Middle East and Africa PET Radiopharmaceuticals by Countries
10.1.1 Middle East and Africa PET Radiopharmaceuticals Sales by Countries
10.1.2 Middle East and Africa PET Radiopharmaceuticals Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa PET Radiopharmaceuticals by Type
10.3 Middle East and Africa PET Radiopharmaceuticals by Application
10.4 Middle East and Africa PET Radiopharmaceuticals by Company

11 Company Profiles
11.1 Cardinal Health Inc. (U.S.)
11.1.1 Cardinal Health Inc. (U.S.) Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of PET Radiopharmaceuticals
11.1.4 PET Radiopharmaceuticals Product Description
11.1.5 Recent Development
11.2 Mallinckrodt plc (Ireland)
11.2.1 Mallinckrodt plc (Ireland) Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of PET Radiopharmaceuticals
11.2.4 PET Radiopharmaceuticals Product Description
11.2.5 Recent Development
11.3 GE Healthcare (U.K.)
11.3.1 GE Healthcare (U.K.) Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of PET Radiopharmaceuticals
11.3.4 PET Radiopharmaceuticals Product Description
11.3.5 Recent Development
11.4 Lantheus Medical Imaging, Inc. (U.S.)
11.4.1 Lantheus Medical Imaging, Inc. (U.S.) Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of PET Radiopharmaceuticals
11.4.4 PET Radiopharmaceuticals Product Description
11.4.5 Recent Development
11.5 Bayer AG (Germany)
11.5.1 Bayer AG (Germany) Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of PET Radiopharmaceuticals
11.5.4 PET Radiopharmaceuticals Product Description
11.5.5 Recent Development
11.6 Bracco Imaging S.p.A (Italy)
11.6.1 Bracco Imaging S.p.A (Italy) Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of PET Radiopharmaceuticals
11.6.4 PET Radiopharmaceuticals Product Description
11.6.5 Recent Development
11.7 Eczacibasi-Monrol Nuclear Products (Turkey)
11.7.1 Eczacibasi-Monrol Nuclear Products (Turkey) Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of PET Radiopharmaceuticals
11.7.4 PET Radiopharmaceuticals Product Description
11.7.5 Recent Development
11.8 Nordion, Inc. (Canada)
11.8.1 Nordion, Inc. (Canada) Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of PET Radiopharmaceuticals
11.8.4 PET Radiopharmaceuticals Product Description
11.8.5 Recent Development
11.9 Advanced Accelerator Applications S.A. (France)
11.9.1 Advanced Accelerator Applications S.A. (France) Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of PET Radiopharmaceuticals
11.9.4 PET Radiopharmaceuticals Product Description
11.9.5 Recent Development
11.10 IBA Molecular Imaging (Belgium)
11.10.1 IBA Molecular Imaging (Belgium) Company Details
11.10.2 Company Description
11.10.3 Sales, Revenue and Gross Margin of PET Radiopharmaceuticals
11.10.4 PET Radiopharmaceuticals Product Description
11.10.5 Recent Development

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key PET Radiopharmaceuticals Raw Material
13.1.2 PET Radiopharmaceuticals Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer


Table of Figures

List of Tables and Figures

Figure Picture of PET Radiopharmaceuticals
Figure Global PET Radiopharmaceuticals Production (K Pcs) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global PET Radiopharmaceuticals Production Market Share by Types (Product Category) in 2017
Figure F-18 Product Picture
Table Major Manufacturers of F-18
Figure Ru-82 Product Picture
Table Major Manufacturers of Ru-82
Figure Others Product Picture
Table Major Manufacturers of Others
Table Global PET Radiopharmaceuticals Market Size Growth Rate by Application 2018-2025 (K Pcs)
Figure Oncology
Figure Cardiology
Figure Neurology
Figure Others
Figure PET Radiopharmaceuticals Report Years Considered
Figure Global PET Radiopharmaceuticals Market Size 2016-2025 (Million US$)
Figure Global PET Radiopharmaceuticals Sales 2016-2025 (K Pcs)
Table Global PET Radiopharmaceuticals Market Size by Regions 2016-2025 (K Pcs) & (Million US$)
Table Global PET Radiopharmaceuticals Sales by Regions 2016-2025 (K Pcs)
Table Global PET Radiopharmaceuticals Sales Market Share by Regions 2016-2025
Figure Global PET Radiopharmaceuticals Sales Market Share by Regions 2016-2025
Figure 2017 Global PET Radiopharmaceuticals Sales Market Share by Regions
Table Global PET Radiopharmaceuticals Revenue by Regions 2016-2025 (Million US$)
Table Global PET Radiopharmaceuticals Revenue Market Share by Regions 2016-2025
Figure Global PET Radiopharmaceuticals Revenue Market Share by Regions 2016-2025
Figure 2017 Global PET Radiopharmaceuticals Revenue Market Share by Regions
Table Global PET Radiopharmaceuticals Sales by Manufacturers (2016-2018) (K Pcs)
Table Global PET Radiopharmaceuticals Sales Share by Manufacturers (2016-2018)
Figure Global PET Radiopharmaceuticals Sales Share by Manufacturers in 2017
Table PET Radiopharmaceuticals Revenue by Manufacturers (2016-2018) (Million US$)
Table PET Radiopharmaceuticals Revenue Share by Manufacturers (2016-2018)
Figure PET Radiopharmaceuticals Value Share by Manufacturers in 2017
Table Global PET Radiopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers PET Radiopharmaceuticals Price (2016-2018) (USD/Pcs)
Table PET Radiopharmaceuticals Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers PET Radiopharmaceuticals Product Category
Table Date of International Manufacturers Enter into PET Radiopharmaceuticals Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global PET Radiopharmaceuticals Sales by Type (2016-2025) (K Pcs)
Table Global PET Radiopharmaceuticals Sales Share by Type (2016-2025)
Figure Global PET Radiopharmaceuticals Sales Market Share by Type (2016-2025)
Figure Global PET Radiopharmaceuticals Sales Market Share by Type in 2017
Table Global PET Radiopharmaceuticals Revenue by Type (2016-2025) (Million US$)
Table Global PET Radiopharmaceuticals Revenue Share by Type (2016-2025)
Figure Global PET Radiopharmaceuticals Revenue Market Share by Type (2016-2025)
Figure Global PET Radiopharmaceuticals Revenue Market Share by Type in 2017
Table PET Radiopharmaceuticals Price by Type 2013-2018 (USD/Pcs)
Table Global PET Radiopharmaceuticals Sales by Application (2016-2025) (K Pcs)
Table Global PET Radiopharmaceuticals Sales Share by Application (2016-2025)
Figure Global Sales PET Radiopharmaceuticals Market Share by Application (2016-2025)
Figure Global Sales PET Radiopharmaceuticals Market Share by Application (2016-2025)
Figure North America PET Radiopharmaceuticals Sales Growth Rate 2016-2025 (K Pcs)
Figure North America PET Radiopharmaceuticals Revenue Growth Rate 2016-2025 (Million US$)
Table North America PET Radiopharmaceuticals Sales by Countries (2016-2025) (K Pcs)
Table North America PET Radiopharmaceuticals Sales Market Share by Countries (2016-2025)
Figure 2017 North America PET Radiopharmaceuticals Sales Market Share by Countries
Table North America PET Radiopharmaceuticals Revenue by Countries (2016-2025) (Million US$)
Table North America PET Radiopharmaceuticals Revenue Market Share by Countries (2016-2025)
Figure 2017 North America PET Radiopharmaceuticals Revenue Market Share by Countries
Figure United States PET Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Pcs)
Figure United States PET Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada PET Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Pcs)
Figure Canada PET Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico PET Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Pcs)
Figure Mexico PET Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
Table North America PET Radiopharmaceuticals Sales by Type (2016-2025) (K Pcs)
Table North America PET Radiopharmaceuticals Sales Market Share by Type (2016-2025)
Figure 2017 North America PET Radiopharmaceuticals Market Share by Type
Table North America PET Radiopharmaceuticals Sales by Application (2016-2025) (K Pcs)
Table North America PET Radiopharmaceuticals Sales Market Share by Application (2016-2025)
Figure 2017 North America PET Radiopharmaceuticals Market Share by Application
Table North America PET Radiopharmaceuticals Sales by Company (2016-2018) (K Pcs)
Table North America PET Radiopharmaceuticals Sales Market Share by Company (2016-2018)
Figure North America PET Radiopharmaceuticals Sales Market Share by Company in 2017
Figure Europe PET Radiopharmaceuticals Sales Growth Rate 2016-2025 (K Pcs)
Figure Europe PET Radiopharmaceuticals Revenue Growth Rate 2016-2025 (Million US$)
Table Europe PET Radiopharmaceuticals Sales by Countries (2016-2025) (K Pcs)
Table Europe PET Radiopharmaceuticals Sales Market Share by Countries (2016-2025)
Figure 2017 Europe PET Radiopharmaceuticals Sales Market Share by Countries
Table Europe PET Radiopharmaceuticals Revenue by Countries (2016-2025) (Million US$)
Table Europe PET Radiopharmaceuticals Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe PET Radiopharmaceuticals Revenue Market Share by Countries
Figure Germany PET Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Pcs)
Figure Germany PET Radiopharmaceuticals Revenue Growth Rate (2016-2025) (K Pcs)
Figure France PET Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Pcs)
Figure France PET Radiopharmaceuticals Revenue Growth Rate (2016-2025) (K Pcs)
Figure UK PET Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Pcs)
Figure UK PET Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy PET Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Pcs)
Figure Italy PET Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia PET Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Pcs)
Figure Russia PET Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
Table Europe PET Radiopharmaceuticals Sales by Type (2016-2025) (K Pcs)
Table Europe PET Radiopharmaceuticals Sales Market Share by Type (2016-2025)
Figure 2017 Europe PET Radiopharmaceuticals Market Share by Type
Table Europe PET Radiopharmaceuticals Sales by Application (2016-2025) (K Pcs)
Table Europe PET Radiopharmaceuticals Sales Market Share by Application (2016-2025)
Figure 2017 Europe PET Radiopharmaceuticals Market Share by Application
Table Europe PET Radiopharmaceuticals Sales by Company (2016-2018) (K Pcs)
Table Europe PET Radiopharmaceuticals Sales Market Share by Company (2016-2018)
Figure Europe PET Radiopharmaceuticals Sales Market Share by Company in 2017
Figure Asia Pacific PET Radiopharmaceuticals Sales Growth Rate 2016-2025 (K Pcs)
Figure Asia Pacific PET Radiopharmaceuticals Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific PET Radiopharmaceuticals Sales by Countries (2016-2025) (K Pcs)
Table Asia Pacific PET Radiopharmaceuticals Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific PET Radiopharmaceuticals Sales Market Share by Countries
Table Asia Pacific PET Radiopharmaceuticals Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific PET Radiopharmaceuticals Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific PET Radiopharmaceuticals Revenue Market Share by Countries
Figure China PET Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Pcs)
Figure China PET Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan PET Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Pcs)
Figure Japan PET Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea PET Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Pcs)
Figure Korea PET Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
Figure India PET Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Pcs)
Figure India PET Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia PET Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Pcs)
Figure Australia PET Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia PET Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Pcs)
Figure Indonesia PET Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia PET Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Pcs)
Figure Malaysia PET Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines PET Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Pcs)
Figure Philippines PET Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand PET Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Pcs)
Figure Thailand PET Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam PET Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Pcs)
Figure Vietnam PET Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore PET Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Pcs)
Figure Singapore PET Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific PET Radiopharmaceuticals Sales by Type (2016-2025) (K Pcs)
Table Asia Pacific PET Radiopharmaceuticals Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific PET Radiopharmaceuticals Market Share by Type
Table Asia Pacific PET Radiopharmaceuticals Sales by Application (2016-2025) (K Pcs)
Table Asia Pacific PET Radiopharmaceuticals Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific PET Radiopharmaceuticals Market Share by Application
Table Asia Pacific PET Radiopharmaceuticals Sales by Company (2016-2018) (K Pcs)
Table Asia Pacific PET Radiopharmaceuticals Sales Market Share by Company (2016-2018)
Figure Asia Pacific PET Radiopharmaceuticals Sales Market Share by Company in 2017
Figure Central & South America PET Radiopharmaceuticals Sales Growth Rate 2016-2025 (K Pcs)
Figure Central & South America PET Radiopharmaceuticals Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America PET Radiopharmaceuticals Sales by Countries (2016-2025) (K Pcs)
Table Central & South America PET Radiopharmaceuticals Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America PET Radiopharmaceuticals Sales Market Share by Countries
Table Central & South America PET Radiopharmaceuticals Revenue by Countries (2016-2025) (Million US$)
Table Central & South America PET Radiopharmaceuticals Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America PET Radiopharmaceuticals Revenue Market Share by Countries
Figure Brazil PET Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Pcs)
Figure Brazil PET Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina PET Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Pcs)
Figure Argentina PET Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America PET Radiopharmaceuticals Sales by Type (2016-2025) (K Pcs)
Table Central & South America PET Radiopharmaceuticals Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America PET Radiopharmaceuticals Market Share by Type
Table Central & South America PET Radiopharmaceuticals Sales by Application (2016-2025) (K Pcs)
Table Central & South America PET Radiopharmaceuticals Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America PET Radiopharmaceuticals Market Share by Application
Table Central & South America PET Radiopharmaceuticals Sales by Company (2016-2018) (K Pcs)
Table Central & South America PET Radiopharmaceuticals Sales Market Share by Company (2016-2018)
Figure Central & South America PET Radiopharmaceuticals Sales Market Share by Company in 2017
Figure Middle East and Africa PET Radiopharmaceuticals Sales Growth Rate 2016-2025 (K Pcs)
Figure Middle East and Africa PET Radiopharmaceuticals Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa PET Radiopharmaceuticals Sales by Countries (2016-2025) (K Pcs)
Table Middle East and Africa PET Radiopharmaceuticals Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa PET Radiopharmaceuticals Sales Market Share by Countries
Table Middle East and Africa PET Radiopharmaceuticals Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa PET Radiopharmaceuticals Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa PET Radiopharmaceuticals Revenue Market Share by Countries
Figure GCC Countries PET Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Pcs)
Figure GCC Countries PET Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey PET Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Pcs)
Figure Turkey PET Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt PET Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Pcs)
Figure Egypt PET Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa PET Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Pcs)
Figure South Africa PET Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa PET Radiopharmaceuticals Sales by Type (2016-2025) (K Pcs)
Table Middle East and Africa PET Radiopharmaceuticals Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa PET Radiopharmaceuticals Market Share by Type
Table Middle East and Africa PET Radiopharmaceuticals Sales by Application (2016-2025) (K Pcs)
Table Middle East and Africa PET Radiopharmaceuticals Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa PET Radiopharmaceuticals Market Share by Application
Table Middle East and Africa PET Radiopharmaceuticals Sales by Company (2016-2018) (K Pcs)
Table Middle East and Africa PET Radiopharmaceuticals Sales Market Share by Company (2016-2018)
Figure Middle East and Africa PET Radiopharmaceuticals Sales Market Share by Company in 2017
Table Cardinal Health Inc. (U.S.) Company Details
Table Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Cardinal Health Inc. (U.S.) Recent Development
Table Mallinckrodt plc (Ireland) Company Details
Table Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Mallinckrodt plc (Ireland) Recent Development
Table GE Healthcare (U.K.) Company Details
Table GE Healthcare (U.K.) PET Radiopharmaceuticals Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table GE Healthcare (U.K.) Recent Development
Table Lantheus Medical Imaging, Inc. (U.S.) Company Details
Table Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Lantheus Medical Imaging, Inc. (U.S.) Recent Development
Table Bayer AG (Germany) Company Details
Table Bayer AG (Germany) PET Radiopharmaceuticals Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Bayer AG (Germany) Recent Development
Table Bracco Imaging S.p.A (Italy) Company Details
Table Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Bracco Imaging S.p.A (Italy) Recent Development
Table Eczacibasi-Monrol Nuclear Products (Turkey) Company Details
Table Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Eczacibasi-Monrol Nuclear Products (Turkey) Recent Development
Table Nordion, Inc. (Canada) Company Details
Table Nordion, Inc. (Canada) PET Radiopharmaceuticals Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Nordion, Inc. (Canada) Recent Development
Table Advanced Accelerator Applications S.A. (France) Company Details
Table Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Advanced Accelerator Applications S.A. (France) Recent Development
Table IBA Molecular Imaging (Belgium) Company Details
Table IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table IBA Molecular Imaging (Belgium) Recent Development
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table PET Radiopharmaceuticals Value Chain
Table Typical Suppliers of Key PET Radiopharmaceuticals Raw Material
Table PET Radiopharmaceuticals Customers List
Table PET Radiopharmaceuticals Sales Channels
Table PET Radiopharmaceuticals Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Request Sample

* mark fields are compulsory